← Back to front page
Europe · Wires & real time · Reuters US Markets

Obesity drug developer Corxel to go public in US via SPAC deal

Published by Reuters US Markets · United Kingdom 11 h ago

Obesity drug developer Corxel Pharmaceuticals will go public in the US through a merger ​with special purpose acquisition company Amanat Acquisition ‌Corp , the companies…

Read the full article on Reuters US Markets Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

Anadolu Agency

Fed expected to hold rates amid accelerating inflation ahead of November US midterms

 Reuters Technology

Japanese companies compensate users as cyberattacks buffet economy

 Reuters Business

FTSE 100 rises as falling oil prices boost risk appetite

 Reuters Asia Markets

Saudi Arabia to store oil in Singapore to bolster Asia supply security

 Reuters

Fed to hit pause on rate hikes, but maybe not for long

 Reuters Sustainable Business

Fed to hit pause on rate hikes, but maybe not for long